Expertise in
15
conditions

Giancarlo Parenti

Naples, IT 
Expertise in
15
conditions
Naples, IT 

Overview

Giancarlo Parenti practices practicing medicine in Naples, Italy.

Mr. Parenti is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), Pompe Disease, Von Gierke Disease, Mucopolysaccharidoses (MPS), and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 120 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Naples, 80131, Italy
Other Locations
Pozzuoli, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Arimoclomol Prospective Double-blind, Randomised, Placebo-controlled Study in Patients Diagnosed With Niemann-Pick Disease Type C
Arimoclomol Prospective Double-blind, Randomised, Placebo-controlled Study in Patients Diagnosed With Niemann-Pick Disease Type C
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Drug
Study Drug: Arimoclomol
Study Phase: Phase 2/Phase 3
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C in Order to Characterise the Individual Patient Disease Profile and Historic Signo-symptomatology Progression Pattern
A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C in Order to Characterise the Individual Patient Disease Profile and Historic Signo-symptomatology Progression Pattern
Enrollment Status: Completed
Publish Date: May 18, 2017
View 1 Less Clinical Trial

120 Total Publications

Uncovering mitochondrial defects in photoreceptors opens therapeutic opportunities for Stargardt disease.
Uncovering mitochondrial defects in photoreceptors opens therapeutic opportunities for Stargardt disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 15, 2026

Frequently Asked Questions about Giancarlo Parenti

Is Giancarlo Parenti a top-rated expert for Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome)?

MediFind is an objective health platform that identifies experts based on real-world data. Giancarlo Parenti is classified as an Distinguished expert for Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Giancarlo Parenti participate in research or clinical trials?

Yes. Giancarlo Parenti has published 120 articles and abstracts on conditions like Mucopolysaccharidosis Type 6 (MPS VI, Maroteaux-Lamy Syndrome). You can view a list of Giancarlo Parenti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Parenti's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 44 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile